David Toung
Stock Analyst at Argus Research
(3.30)
# 1,048
Out of 4,981 analysts
126
Total ratings
63.54%
Success rate
9.36%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Buy | $105 → $115 | $94.25 | +22.02% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $278.72 | +1.17% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $314.89 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $32.17 | +61.64% | 1 | Jul 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $620 → $470 | $491.41 | -4.36% | 7 | Apr 29, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $353.61 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $15.47 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $220.22 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $152.47 | -18.02% | 9 | Sep 11, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $159.74 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $282.73 | +20.26% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $719.80 | -6.92% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $104.26 | +43.87% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $756.28 | +11.07% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $95 | $66.53 | +42.79% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $77.96 | +41.10% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $279.72 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $24.86 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $388.79 | -20.27% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $402.85 | -23.05% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $455.85 | -29.80% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $132.65 | +1.77% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $117.86 | -36.37% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $47.54 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $85.15 | +29.18% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.77 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $53.21 | +130.22% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $81.10 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $127.70 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $178.50 | -13.17% | 4 | Mar 27, 2020 |
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $94.25
Upside: +22.02%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $278.72
Upside: +1.17%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $314.89
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $32.17
Upside: +61.64%
Thermo Fisher Scientific
Apr 29, 2025
Maintains: Buy
Price Target: $620 → $470
Current: $491.41
Upside: -4.36%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $353.61
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $15.47
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $220.22
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $152.47
Upside: -18.02%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $159.74
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $282.73
Upside: +20.26%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $719.80
Upside: -6.92%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $104.26
Upside: +43.87%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $756.28
Upside: +11.07%
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $66.53
Upside: +42.79%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $77.96
Upside: +41.10%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $279.72
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $24.86
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $388.79
Upside: -20.27%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $402.85
Upside: -23.05%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $455.85
Upside: -29.80%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $132.65
Upside: +1.77%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $117.86
Upside: -36.37%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $47.54
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $85.15
Upside: +29.18%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $7.77
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $53.21
Upside: +130.22%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $81.10
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $127.70
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $178.50
Upside: -13.17%